High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study
Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies
Relationship between motor symptoms and brain metabolism in early Huntington’s disease
A randomized, Double-Blind, placebo-controlled trial evaluating cystéamine in Huntington’s disease
Prosodic Cues Enhance Rule Learning by Changing Speech Segmentation Mechanisms
Somatosensory cortical activations are suppressed in patients with tactile extinction: a PET study.
Decision-making capacity and surrogate designation in French ICU patients
Retest effects and cognitive decline in longitudinal follow-up of patients with early HD
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: Results of a phase I study
Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study